Assessing the Neurodevelopmental Impact of Fluoxetine, Citalopram, and Paroxetine on Neural Stem Cell-Derived Neurons
Open Access
- 18 October 2024
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (10) , 1392
Abstract
Background/Objectives: Many pregnant women globally suffer from depression and are routinely prescribed selective serotonin reuptake inhibitors (SSRIs). These drugs function by blocking the re-uptake of serotonin by the serotonin transporter (SERT) into neurons, resulting in its accumulation in the presynaptic cleft. Despite a large amount of research suggesting a potential link to neurodevelopmental disorders in children whose mothers took these drugs during pregnancy, their possible adverse effects are still debated, and results are contradictory. On the other hand, there is an immediate need for improved cell-based models for developmental neurotoxicity studies (DNT) to minimize the use of animals in research. Methods: In this study, we aimed to assess the effects of clinically relevant concentrations of paroxetine (PAR), fluoxetine (FLX), and citalopram (CIT)—on maturing neurons derived from human neural stem cells using multiple endpoints. Results: Although none of the tested concentrations of FLX, CIT, or PAR significantly affected cell viability, FLX (10 µM) exhibited the highest reduction in viability compared to the other drugs. Regarding neurite outgrowth, CIT did not have a significant effect. However, FLX (10 µM) significantly reduced both mean neurite outgrowth and mean processes, PAR significantly reduced mean processes, and showed a trend of dysregulation of multiple genes associated with neuronal development at therapeutic-relevant serum concentrations. Conclusions: Transcriptomic data and uptake experiments found no SERT activity in the system, suggesting that the adverse effects of FLX and PAR are independent of SERT.Keywords
Funding Information
- Swedish Research Council
- Åhlen Foundation
- Gunvor and Josef Anérs Foundation
This publication has 105 references indexed in Scilit:
- Neurotoxicity and underlying cellular changes of 21 mitochondrial respiratory chain inhibitorsArchives of Toxicology, 2021
- Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in OffspringJAMA Psychiatry, 2016
- Prenatal exposure to selective serotonin reuptake inhibitors (SSRI) increases aggression and modulates maternal behavior in offspring miceDevelopmental Psychobiology, 2015
- Autistic and Rett‐like features associated with 2q33.3–q34 interstitial deletionAmerican Journal of Medical Genetics Part A, 2015
- Alterations in GABAergic Biomarkers in the Autism Brain: Research Findings and Clinical ImplicationsThe Anatomical Record, 2011
- Quantitative determination of fluoxetine in human serum by high performance thin layer chromatographyJournal of Separation Science, 2010
- Candidate gene studies of ADHD: a meta-analytic reviewHuman Genetics, 2009
- The Reelin Gene and Its Functions in Brain Development2008
- Paroxetine in the first trimester and the prevalence of congenital malformationsPharmacoepidemiology and Drug Safety, 2007
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001